A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1
Patients with neurofibromatosis type 1 develop both benign and malignant tumors at an increased frequency. Most of the malignant peripheral nerve sheath tumors (MPNSTs) are considered as high-grade sarcomas originating from tissues of mesenchymal origin. It is generally accepted that MPNSTs occur in...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2012-01-01
|
Series: | Case Reports in Otolaryngology |
Online Access: | http://dx.doi.org/10.1155/2012/936735 |
id |
doaj-b912bdc637844955ac32a42b16ac6296 |
---|---|
record_format |
Article |
spelling |
doaj-b912bdc637844955ac32a42b16ac62962020-11-24T23:57:51ZengHindawi LimitedCase Reports in Otolaryngology2090-67652090-67732012-01-01201210.1155/2012/936735936735A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1Özmen Öztürk0Alper Tutkun1Department of Otorhinolaryngology, School of Medicine, Istanbul Medipol University, Istanbul, TurkeyDepartment of Otorhinolaryngology, Academic Hospital, Istanbul, TurkeyPatients with neurofibromatosis type 1 develop both benign and malignant tumors at an increased frequency. Most of the malignant peripheral nerve sheath tumors (MPNSTs) are considered as high-grade sarcomas originating from tissues of mesenchymal origin. It is generally accepted that MPNSTs occur in about 2% to 5% of neurofibromatosis patients. In this paper, we present a 16-year-old male patient with neurofibromatosis who developed MPNST of the retromolar area. The mass enlarged rapidly in a period of 6 weeks. The patient was treated surgically, and a tumor mass with a diameter of cm was excised, but after 8 months a recurrence was observed at the same site. The sarcomatous change in a neurofibroma has an extremely poor prognosis, so patients with neurofibromatosis should be closely monitored for a possible malignancy. A rapid change in size of a preexisting neurofibroma, infiltration of the adjacent structures, intralesional hemorrhage, and pain indicate a possible malignant transformation to MPNST.http://dx.doi.org/10.1155/2012/936735 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Özmen Öztürk Alper Tutkun |
spellingShingle |
Özmen Öztürk Alper Tutkun A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1 Case Reports in Otolaryngology |
author_facet |
Özmen Öztürk Alper Tutkun |
author_sort |
Özmen Öztürk |
title |
A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1 |
title_short |
A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1 |
title_full |
A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1 |
title_fullStr |
A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1 |
title_full_unstemmed |
A Case Report of a Malignant Peripheral Nerve Sheath Tumor of the Oral Cavity in Neurofibromatosis Type 1 |
title_sort |
case report of a malignant peripheral nerve sheath tumor of the oral cavity in neurofibromatosis type 1 |
publisher |
Hindawi Limited |
series |
Case Reports in Otolaryngology |
issn |
2090-6765 2090-6773 |
publishDate |
2012-01-01 |
description |
Patients with neurofibromatosis type 1 develop both benign and malignant tumors at an increased frequency. Most of the malignant peripheral nerve sheath tumors (MPNSTs) are considered as high-grade sarcomas originating from tissues of mesenchymal origin. It is generally accepted that MPNSTs occur in about 2% to 5% of neurofibromatosis patients. In this paper, we present a 16-year-old male patient with neurofibromatosis who developed MPNST of the retromolar area. The mass enlarged rapidly in a period of 6 weeks. The patient was treated surgically, and a tumor mass with a diameter of cm was excised, but after 8 months a recurrence was observed at the same site. The sarcomatous change in a neurofibroma has an extremely poor prognosis, so patients with neurofibromatosis should be closely monitored for a possible malignancy. A rapid change in size of a preexisting neurofibroma, infiltration of the adjacent structures, intralesional hemorrhage, and pain indicate a possible malignant transformation to MPNST. |
url |
http://dx.doi.org/10.1155/2012/936735 |
work_keys_str_mv |
AT ozmenozturk acasereportofamalignantperipheralnervesheathtumoroftheoralcavityinneurofibromatosistype1 AT alpertutkun acasereportofamalignantperipheralnervesheathtumoroftheoralcavityinneurofibromatosistype1 AT ozmenozturk casereportofamalignantperipheralnervesheathtumoroftheoralcavityinneurofibromatosistype1 AT alpertutkun casereportofamalignantperipheralnervesheathtumoroftheoralcavityinneurofibromatosistype1 |
_version_ |
1725453076836384768 |